Search
for
Sort by
Research 30 of 261
- Pilot study: genetic distribution of AR, FGF5, SULT1A1 and CYP3A5 polymorphisms in male Mexican population with androgenetic alopecia.
- Cloning of a Functional Vitamin D Receptor from the Lamprey (Petromyzon marinus), an Ancient Vertebrate Lacking a Calcified Skeleton and Teeth
- Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study
- Arecaceae
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Drug safety evaluation of exemestane
- A population pharmacokinetic model for individualized regimens of finasteride according to CYP3A5 genotype and liver function
- SAT340 Matters Of The HAART - Ritonavir Induced CYP3A4 Inhibition of Intranasal Fluticasone Leading To Cushing’s Syndrome
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives
- Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride
- The Rotterdam Study: 2016 objectives and design update
- Hair Loss in Women
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- A genomic approach to susceptibility and pathogenesis leads to identifying potential novel therapeutic targets in androgenetic alopecia
- Androgenetic Alopecia in Men: An Update On Genetics
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- USO DO MINOXIDIL PARA TRATAMENTO DE ALOPECIA ANDROGENÉTICA
- Case Report: PTCH1 splice-site mutation and sonidegib treatment in Gorlin-Goltz syndrome: clinical insights from a family case study
- Congenital adrenal hyperplasia
- Role of skin enzymes in metabolism of topical drugs
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Ritlecitinib in severe alopecia areata: a profile of its use